Mohammed Hankir, PhD

Dr. Hankir studied neuroscience at the University of Leeds and University College London before undertaking a PhD in metabolism at Imperial College London. For his doctoral thesis, he employed in vivo imaging techniques such as manganese-enhanced MRI and PET to study mouse hypothalamic neuronal activity and rat brown fat activity in response to gut hormones and gastric bypass surgery, respectively. After brief post doctoral positions at the University of Oxford and then at the MRC London Institute of Medical Sciences, he moved to University Hospital Leipzig and then to University Hospital Würzburg to work mainly on the mechanisms behind weight loss and improved glycemic control after gastric bypass surgery. Dr. Hankir is currently working as a Senior Scientist on a Novo Nordisk-funded consortium to characterise the central mechanisms of action of semaglutide and cagrilintide. Dr. Hankir has made numerous contributions to the field of metabolism including the characterisation of a novel gut-brain pathway that mediates suppressed fat appetite after gastric bypass surgery as well as identifying novel means of activating brown fat thermogenesis for therapeutic gain. Dr. Hankir serves as an Academic Editor for the journal Cell Stress and is a Scientific Advisory Board Member for the Norwegian Nuclear Medicine Consortium.
Mohammed Hankir.JPG